Patients with community acquired pneumonia admitted to European intensive care units: An epidemiological survey of the GenOSept cohort

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Walden, Andrew P ^a   Clarke, Geraldine M ^b   McKechnie, Stuart ^c   Hutton, Paula ^c   Gordon, Anthony C ^d   Rello, Jordi ^e   Chiche, Jean Daniel ^f   Stueber, Frank ^g   Garrard, Christopher S ^c   Hinds, Charles J ^h  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Hospital Cochin ^*  (France)

^g UNIVERSITY OF BERN   (Switzerland)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BILIRUBIN; CREATININE; POTASSIUM; SODIUM; UREA;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; BREATHING RATE; CARBON DIOXIDE TENSION; CHLAMYDOPHILA PSITTACI; COMMUNITY ACQUIRED PNEUMONIA; EUROPE; FEMALE; HAEMOPHILUS INFLUENZAE; HEART RATE; HEMATOCRIT; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KLEBSIELLA; LEGIONELLA PNEUMOPHILA; LEUKOCYTE COUNT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MYCOPLASMA PNEUMONIAE; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTOLIC BLOOD PRESSURE; TEMPERATURE; THROMBOCYTE COUNT; URINE VOLUME; ADOLESCENT; AGED; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; FOLLOW UP; HOSPITAL ADMISSION; INFORMATION PROCESSING; MIDDLE AGED; MULTICENTER STUDY; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DATA COLLECTION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84899631060     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13812     Document Type: Article

References (45)

1. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987, 1:671-674.
2. Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Karkola K, Korppi M, Kurki S, Ronnberg PR, Seppa A, Soimakallio S, Stén M, Tanska S, Tarkiainen A, Tukiainen H, Pyörälä K, Mäkelä PH. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993, 137:977-988.
3. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167:1655-1663. 10.1001/archinte.167.15.1655, 17698689.
4. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997, 10:1530-1534. 10.1183/09031936.97.10071530, 9230242.
5. Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodriguez-Roisin R. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 1991, 144:312-318. 10.1164/ajrccm/144.2.312, 1859053.
6. Almirall J, Mesalles E, Klamburg J, Parra O, Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995, 107:511-516. 10.1378/chest.107.2.511, 7842786.
7. The British Thoracic Society Research Committee and The Public HealthLaboratory Service The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir Med 1992, 86:7-13. 10.1016/S0954-6111(06)80141-1, 1565823, The British Thoracic Society Research Committee and The Public HealthLaboratory Service.
8. Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008, 14:727-733. 10.3201/eid1405.071011, 2600241, 18439353.
9. Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2009, 36:612-620.
10. Woodhead MA, Macfarlane JT, Rodgers FG, Laverick A, Pilkington R, Macrae AD. Aetiology and outcome of severe community-acquired pneumonia. J Infect 1985, 10:204-210. 10.1016/S0163-4453(85)92463-6, 4031512.
11. Hirani NA, Macfarlane JT. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 1997, 52:17-21. 10.1136/thx.52.1.17, 1758402, 9039234.
12. Alkhayer M, Jenkins PF, Harrison BD. The outcome of community acquired pneumonia treated on the intensive care unit. Respir Med 1990, 84:13-16. 10.1016/S0954-6111(08)80087-X, 2115190.
13. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest 1994, 105:1487-1495. 10.1378/chest.105.5.1487, 8181342.
14. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160:397-405. 10.1164/ajrccm.160.2.9808045, 10430704.
15. Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990, 142:369-373. 10.1164/ajrccm/142.2.369, 2382902.
16. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, Beaucaire G. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995, 21:24-31. 10.1007/BF02425150, 7560469.
17. Olaechea PM, Quintana JM, Gallardo MS, Insausti J, Maravi E, Alvarez B. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med 1996, 22:1294-1300. 10.1007/BF01709541, 8986476.
18. Ortqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985, 17:377-386.
19. Rello J, Quintana E, Ausina V, Net A, Prats G. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993, 103:232-235. 10.1378/chest.103.1.232, 8417885.
20. Sorensen J, Forsberg P, Hakanson E, Maller R, Sederholm C, Soren L, Carlsson C. A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989, 21:33-41. 10.3109/00365548909035678, 2727627.
21. Bodi M, Rodriguez A, Sole-Violan J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005, 41:1709-1716. 10.1086/498119, 16288392.
22. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Genin R, Yvin JL. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 2004, 24:779-785.
23. The British Thoracic Society and the Public Health Laboratory Service Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987, 62:195-220. The British Thoracic Society and the Public Health Laboratory Service.
24. Angus DC, Marrie TJ, Obrosky DS, Clermont G, Dremsizov TT, Coley C, Fine MJ, Singer DE, Kapoor WN. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002, 166:717-723. 10.1164/rccm.2102084, 12204871.
25. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?. Chest 2006, 129:968-978. 10.1378/chest.129.4.968, 16608946.
26. Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Grayson ML, Australian Community-Acquired Pneumonia Study C SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008, 47:375-384. 10.1086/589754, 18558884, Australian Community-Acquired Pneumonia Study C.
27. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500.
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
29. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
30. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Antonio T, Whitney CG. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72. 10.1086/511159, 17278083.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
32. Therneau TMGP. Modeling survival data: extending the Cox model 2000, New York: Springer, 1.
33. Woodhead M, Welch CA, Harrison DA, Bellingan G, Ayres JG. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care 2006, 10:S1.
34. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, Kong L, Carter M, Angus DC. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008, 177:1242-1247. 10.1164/rccm.200712-1777OC, 2720087, 18369199.
35. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010, 38:1276-1283.
36. Granja C, Dias C, Costa-Pereira A, Sarmento A. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care 2004, 8:R91-R98. 10.1186/cc2818, 420036, 15025783.
37. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl 2002, 36:20s-27s.
38. Gutierrez F, Masia M, Rodriguez JC, Ayelo A, Soldan B, Cebrian L, Mirete C, Royo G, Hidalgo AM. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003, 36:286-292. 10.1086/345852, 12539069.
39. Lasocki S, Scanvic A, Le Turdu F, Restoux A, Mentec H, Bleichner G, Sollet JP. Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia. Intensive Care Med 2006, 32:1766-1772. 10.1007/s00134-006-0329-9, 16957905.
40. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008, 134:1141-1148. 10.1378/chest.08-0888, 18689592.
41. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS, Canadian Critical Care Trials Group One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693. 10.1056/NEJMoa022450, 12594312, Canadian Critical Care Trials Group.
42. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
43. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
44. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
45. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002, 30:2051-2058. 10.1097/00003246-200209000-00016, 12352040.